These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6509988)

  • 1. Development of a low-dose monthly injectable contraceptive system: I. Choice of compounds, dose and administration route.
    Garza-Flores J; Diaz-Sanchez V; Jimenez-Thomas S; Rudel HW
    Contraception; 1984 Oct; 30(4):371-9. PubMed ID: 6509988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of 19-nor-testosterone type of contraceptive steroids through different drug delivery systems into serum and breast milk of lactating women.
    Toddywalla VS; Mehta S; Virkar KD; Saxena BN
    Contraception; 1980 Mar; 21(3):217-23. PubMed ID: 7389350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations.
    Brenner PF; Goebelsmann U; Stanczyk FZ; Mishell DR
    Contraception; 1980 Jul; 22(1):85-95. PubMed ID: 7418409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroids.
    Stanczyk FZ; Brenner PF; Mishell DR; Ortiz A; Gentzschein EK; Goebelsmann U
    Contraception; 1978 Dec; 18(6):615-33. PubMed ID: 750188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Werawatgoompa S; Vaivanijkul B; Leepipatpaiboon S; Channiyom K; Virutamasen P; Dusitsin N
    Contraception; 1980 Mar; 21(3):299-309. PubMed ID: 7389353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of norethindrone and ethinyl estradiol for two different weight tablets with the same hormonal content.
    Saperstein S; Edgren RA; Ellis DJ; Lee GJ; Kushinsky S; Olmsted A; Mroszczak E
    Contraception; 1986 Jun; 33(6):547-57. PubMed ID: 3769481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New long-acting injectable microcapsule contraceptive system.
    Beck LR; Cowsar DR; Lewis DH; Gibson JW; Flowers CE
    Am J Obstet Gynecol; 1979 Oct; 135(3):419-26. PubMed ID: 114054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL; Roy S; Lobo RA
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone levels and anogenital swelling of female chimpanzees as a function of estrogen dosage in a combined oral contraceptive.
    Nadler RD; Dahl JF; Collins DC; Gould KG
    Proc Soc Exp Biol Med; 1992 Oct; 201(1):73-9. PubMed ID: 1528911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I; Zaki K; Rashad S
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the progestogens, gestodene, 3-keto desogestrel, levonorgestrel, norethisterone and norgestimate on the oxidation of ethinyloestradiol and other substrates by human liver microsomes.
    Back DJ; Houlgrave R; Tjia JF; Ward S; Orme ML
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):219-25. PubMed ID: 2004043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins.
    McGuire JL; Bariso CD; Yuliano E; Hume RJ; Pasquale SA
    Contraception; 1975 Mar; 11(3):329-38. PubMed ID: 1116369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a new low-dose once-a-month injectable contraceptive.
    Garza-Flores J; Jimenez-Thomas S; Salomón-Andonie J; Díaz-Sanchez V
    Contraception; 1988 May; 37(5):471-81. PubMed ID: 3409701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.